Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2012

View Archived Issues

Scientists in Germany develop novel model for chronic lung allograft damage

Chinese study assesses plasma amino acid profiles as predictors of depression severity

FDA issues complete response letter for Relistor sNDA

New European approval for Afinitor

AnGes plans Japanese study of gene therapy for lymphedema

New siRNA delivery method achieves selective targeting for prevention of organ rejection

Novel NADK inhibitors discovered in France

Cadila Healthcare divulges novel LDL receptor ligands

New antiviral agents presented

Novel arginase inhibitors disclosed by Corridor Pharmaceuticals

Novel acetyl-CoA carboxylase inhibitors developed in India

Merck Serono creates first spin-off from Entrepreneur Partnership Program

Tonix Pharmaceuticals completes study of sublingual TNX-102

FDA grants priority review to cabozantinib NDA

SNS01-T obtains FDA orphan drug status in two new indications

Japanese team designs new MGAT2 inhibitors

Palau Pharma signs exclusive agreement with Sensorion Pharmaceuticals

Auxilium Pharmaceuticals reports topline data on Xiaflex

Amgen profiles progress of second quarter 2012

New model uses transgenic pigs to study hepatocyte transplants

Gilead Sciences reports results for the second quarter of 2012

EC approves first drug for nonradiographic severe axial spondyloarthritis

Bristol-Myers Squibb updates progress of second quarter 2012

FDA issues complete response letter for rilonacept sBLA

Ariad submits NDA for ponatinib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...